George Yancopoulos, Bd. Co-Chair, President & CSO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 16,848 shares at $900.00 ($15.2M) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($15.2M) by Bd. Co-Chair, President & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |
| REGN | SELL | 2021-08-17 | $62.0M | — | Filing → |